Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,285 | 21,005 | 16,987 | 23,462 | 39,631 |
| Marketable Securities | 69,336 | 85,494 | 109,871 | 117,500 | 114,238 |
| TOTAL | $93,107 | $110,170 | $131,253 | $144,951 | $156,893 |
| Non-Current Assets | |||||
| PPE Net | 2,712 | 2,919 | 3,048 | 3,095 | 3,141 |
| Other Non-Current Assets | 261 | 236 | 283 | 300 | 187 |
| TOTAL | $2,973 | $3,155 | $3,331 | $3,395 | $3,328 |
| Total Assets | $96,080 | $113,325 | $134,584 | $148,346 | $160,221 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 882 | 934 | 978 | 1,017 | 1,047 |
| Accounts payable and accrued liabilities | 3,217 | 2,047 | 2,590 | 2,950 | 2,273 |
| Accrued Expenses | 9,620 | 10,321 | 15,012 | 11,524 | 8,510 |
| TOTAL | $13,889 | $13,472 | $19,287 | $17,155 | $14,326 |
| Non-Current Liabilities | |||||
| Long Term Debt | 730 | 939 | 1,156 | 1,255 | 1,439 |
| Deferred Revenues | 170 | 170 | 707 | 1,664 | 2,496 |
| Other Non-Current Liabilities | 257 | 247 | 207 | 202 | 186 |
| TOTAL | $987 | $1,186 | $1,363 | $1,457 | $1,625 |
| Total Liabilities | $14,876 | $14,658 | $20,650 | $18,612 | $15,951 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,130 | 37,088 | 37,059 | 36,967 | 36,947 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -264,523 | -246,236 | -229,856 | -212,818 | -196,773 |
| Other shareholders' equity | 307 | 668 | 493 | 433 | 297 |
| TOTAL | $81,204 | $98,667 | $113,934 | $129,734 | $144,270 |
| Total Liabilities And Equity | $96,080 | $113,325 | $134,584 | $148,346 | $160,221 |